DUAMIVE



Trademark Coverage

No Class Specified

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction and pain; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use

Owner

Pfizer Inc.

Business in New York, NY

Owns 3395 trademarks

Timeline
  • Feb 10
    2014
    Abandonment Notice Mailed No Use Statement Filed
  • Feb 10
    2014
    Abandonment No Use Statement Filed
  • Jul 09
    2013
    NOA E Mailed SOU Required From Applicant
  • May 14
    2013
    Official Gazette Publication Confirmation E Mailed
  • May 14
    2013
    Published For Opposition
  • Apr 24
    2013
    Notification Of Notice Of Publication E Mailed
  • Apr 09
    2013
    Law Office Publication Review Completed
  • Apr 03
    2013
    Assigned To LIE
  • Apr 02
    2013
    Approved For PUB Principal Register
  • Mar 26
    2013
    TEAS/Email Correspondence Entered
  • Mar 26
    2013
    Correspondence Received In Law Office
  • Mar 26
    2013
    TEAS Response To Suspension Inquiry Received
  • Mar 13
    2013
    Notification Of Letter Of Suspension E Mailed
  • Mar 13
    2013
    Letter Of Suspension E Mailed
  • Mar 13
    2013
    Suspension Letter Written
  • Mar 11
    2013
    Assigned To Examiner
  • Feb 09
    2013
    New Application Office Supplied Data Entered In TRAM
  • Feb 08
    2013
    New Application Entered In TRAM